Tilray Brands, Inc. TLRY

Alternate Symbol(s): T.TLRY

Healthcare Cannabis

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.

NDAQ:TLRY - Post by User

Tilray Brands, Inc. > The biggest reason I am due diligenceing on TLRY

<< Previous

Bullboard Posts

Next >>

Comment by DaveInCalgaryon Oct 24, 2023 10:09pm

123 Views

Post# 35699376

RE:The biggest reason I am due diligenceing on TLRY

I'll stay for the most part in TLRY. I know they have built a great protected medical cannabis position in Germany.

https://www.bundesgesundheitsministerium.de/presse/pressemitteilungen/bundeskabinett-beschliesst-cannabisgesetz-pm-16-08-23.html

Check Question 41 & 42. Tilray & ACB have #42 tied down.

Federal Cabinet passes cannabis law

Questions and answers about the cannabis law

Medical cannabis

Yes. Medical cannabis should be legally clearly separated from cannabis for non-medical purposes. Medical cannabis is therefore not regulated in the Cannabis Act, but in a separate Medical Cannabis Act. The content of the existing regulations on medical cannabis remains essentially unchanged. Medical cannabis may continue to be prescribed as a medicine in accordance with the applicable social law requirements. However, a prescription for a special narcotic prescription will no longer be necessary in the future. A regular recipe is sufficient here.
No. The cultivation of cannabis continues to be carried out by companies that were selected in a Europe-wide tender process and commissioned by the Cannabis Agency at the Federal Institute for Drugs and Medical Devices. This cannabis is grown exclusively for medical purposes in accordance with pharmaceutical quality requirements. The prescription requirement remains.

The last reading held in the Bundestag Oct 18, 2023, 2 German companies that were late getting involved in medical cannabis were complaining that foreign companies had medical market.

Tilray also mentioned drinks into Europe, that could really go well.

Hexo & Truss being moved into new facilities in London. I'm sure with plenty of capacity.
Wonder if anyone knows about the London facility? CaneIsAbel?